Back

Enleofen’s recent deal Singapore’s life science start-up

A small team of creative and committed innovators behind start-up biotechnology company, Enleofen, a spin-out of Duke-NUS Medical School and the National Heart Centre Singapore, has shown it is possible to commercialise long-horizon technologies in Singapore. Read more>>



The Enleofen team, bottom row from left to right, Operations Manager Susanne Weber, Director and Co-Founder Professor Stuart Cook and Director Jeffrey Lu, top row from left to right, Director Andrew Khoo, Co-Founder Asst Prof Sebastian Schäfer and IP Advisor Guy Heathers.